Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Financial Flexibility Index
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Financial Flexibility Index of 0.59x as of December 2025. Free cash flow of CN¥468.43 Million (operating CF CN¥345.31 Million minus capex CN¥123.12 Million) represents 1% of total liabilities (CN¥797.40 Million). Check financial resilience of Jiangsu Hualv Biological Technology Co.L to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu Hualv Biological Technology Co.Ltd. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. See 300970 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year free cash flow to debt coverage for Jiangsu Hualv Biological Technology Co.Ltd.. For the full company profile including market capitalisation, see 300970 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | CN¥468.43 Million | CN¥345.31 Million | CN¥797.40 Million | ▲ +13.7% |
| 2024 | 0.52x | CN¥406.01 Million | CN¥137.80 Million | CN¥786.12 Million | ▼ -27.2% |
| 2023 | 0.71x | CN¥390.83 Million | CN¥166.67 Million | CN¥551.03 Million | ▼ -44.8% |
| 2022 | 1.28x | CN¥587.75 Million | CN¥179.84 Million | CN¥457.83 Million | ▲ +96.2% |
| 2021 | 0.65x | CN¥287.17 Million | CN¥83.08 Million | CN¥438.92 Million | ▼ -47.4% |
| 2020 | 1.24x | CN¥390.05 Million | CN¥199.09 Million | CN¥313.67 Million | ▲ +11.6% |
| 2019 | 1.11x | CN¥312.51 Million | CN¥213.96 Million | CN¥280.52 Million | — |